IVI Aflibercept Before and After Phaco in DME.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

August 1, 2022

Study Completion Date

December 1, 2022

Conditions

Diabetic Macular Edema

Interventions

PROCEDURE

Phacoemulsification with IVI of aflibercept

IVI was either before or after cataract surgery

Trial Locations (1)

Ahady Hospital, Al Qādisīyah

All Listed Sponsors

lead

Al Hadi Hospital

OTHER

NCT05731089 - IVI Aflibercept Before and After Phaco in DME. | Biotech Hunter | Biotech Hunter